1)日本精神神経学会, 日本産科婦人科学会(監修): 精神疾患を合併した, 或いは合併の可能性のある妊産婦の診療ガイド 総論編. 日本精神神経学会, 2020
2)各論9てんかん. 日本精神神経学会, 日本産科婦人科学会(監修): 精神疾患を合併した, 或いは合併の可能性のある妊産婦の診療ガイド 各論編. 日本精神神経学会, 2022
3)Tomson T, Battino D, Bromley R, Kochen S, Meador K, et al: Management of epilepsy in pregnancy: a report from the International League Against Epilepsy Task Force on Women and Pregnancy. Epileptic Disord 21: 497-517, 2019
4)日本神経学会(監修), 「てんかん診療ガイドライン」作成委員会(編): てんかん診療ガイドライン2018. 医学書院, 東京, 2018
5)Meador KJ, Baker GA, Browning N, Cohen MJ, Bromley RL, et al; NEAD Study Group: Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study. Lancet Neurol 12: 244-252, 2013
6)Christensen J, Grønborg TK, Sørensen MJ, Schendel D, Parner ET, et al: Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA 309: 1696-1703, 2013
7)Vegrim HM, Dreier JW, Alvestad S, Gilhus NE, Gissler M, et al: Cancer risk in children of mothers with epilepsy and high-dose folic acid use during pregnancy. JAMA Neurol 79: 1-10, 2022
8)国立成育医療研究センター: 妊娠と薬情報センター. https://www.ncchd.go.jp/kusuri/(最終閲覧日: 2022年12月2日)
9)Egawa M, Hara K, Ikeda M, Kono E, Miyashita S, et al: Role of obstetricians in promoting pregnancy-related knowledge among women with epilepsy in Japan. Epilepsy Behav 111: 107176, 2020[doi: 10.1016/j.yebeh.2020.107176]
10)Tokumitsu K, Sugawara N, Maruo K, Suzuki T, Shimoda K, et al: Prevalence of perinatal depression among Japanese women: a meta-analysis. Ann Gen Psychiatry 19: 41, 2020[doi: 10.1186/s12991-020-00290-7]
11)Bjørk MH, Veiby G, Engelsen BA, Gilhus NE: Depression and anxiety during pregnancy and the postpartum period in women with epilepsy: A review of frequency, risks and recommendations for treatment. Seizure 28: 39-45, 2015
12)Takubo Y, Tsujino N, Aikawa Y, Fukiya K, Iwai M, et al: Psychological impacts of the COVID-19 pandemic on one-month postpartum mothers in a metropolitan area of Japan. BMC Pregnancy Childbirth 21: 845, 2021[doi: 10.1186/s12884-021-04331-1]